Join us at @IDWeekmtg
Introducing ONETest™ PathoGenome — a new class of metagenomic assay that captures core genomes across 50 microbial families to identify pathogens with species-level precision.
📅 Oct 22 | 8 AM
📍 B302-304
#Diagnostics #Metagenomics #infectiousdiseases
Fusion Genomics retweeted
Officials at @fusiongenomics say the company has set up a fully automated, first-of-its-kind infectious-disease surveillance facility at Toronto Pearson International Airport. Read more: ow.ly/Pc8350MnH9a
Join to learn how we plan to put sequencing base diagnostics in every laboratory! #IDWeek2022
At #IDWeek2022 ?
join in to learn how how our disruptive ONETest assay enables broader, faster, less costly genomic testing for infectious diseases.
Fusion Genomics retweeted
Replying to @SupRichmondBC
@SupRichmondBC is now our new home. Also a big thanks to @cbreCanada team.
Attending #LSINW2022 Visit Booth 318 Device Showcase & learn about ONETest Lab-on-a-Chip
Today at #LSINW2022 CSO @mqadir_FG Presenting in the Diagnostics stream, Room 606, 11:30 AM. Join us for a presentation on how we plan to solve the diagnostic & adoption challenges for genomic testing in #infectious diseases. Program
lifesciencewa.org/events/lif…
Fusion Genomics is at #LSINW2022 CSO @mqadir_FG Presenting in the Diagnostics stream. Join us for a presentation on how we plan to solve the diagnostic and adoption challenges for genomic testing in #infectiousdiseases. Register now: bit.ly/3iz6mFf
We're excited about this new pilot study with @TorontoPearson. Our sequencing-based #ONETest platform will be used to analyze volunteer samples for #COVID19 & other respiratory pathogens to track variants & spot new pandemic threats. Learn more:
businesswire.com/news/home/2…
As new #COVID19 #variants continue to emerge, we need more complete information about viral genomes. A study conducted w/ @UFMedicine, now published in Diagnostic Microbiology and Infectious Diseases, shows our ONETest can meet this challenge. sciencedirect.com/science/ar…
As new #COVID19 variants continue to emerge, we need more complete information about viral genomes. A study conducted w/ @UFMedicine, now published in Diagnostic Microbiology and Infectious Diseases, shows our ONETest can meet this challenge. sciencedirect.com/science/ar…
Fusion Genomics retweeted
BC #lifesciences at #BioDigital2021; world-class biotech research and innovation at work in our province. @fusiongenomics aims to take “undiagnosed infection” out of medical vocabulary through advance genomics technologies
#LSBCMember #BCBioTech #BioDigitalCDN
Interested in applying your #NGS skills to design & execute complex experiments interfacing #synbio & high throughput screening in the development of clinical assays? We're looking for a junior lab scientist/postdoc to join our growing #Vancouver team buff.ly/2Pjd1sc
Experienced in developing & validating NGS assays, or in the use of sequencing & automated liquid handling tech? We're looking for a senior laboratory technician to join our growing #Vancouver team. Pass it on! #sciencejobs #hiring buff.ly/3sFyv10
#DYK: Widely used #COVID19 amplicon-NGS methods rely on stable regions of the SARS-CoV-2 genome, and may fail to sequence emerging variants. See how our ONETest target capture NGS approach stacked up. buff.ly/2P1ZNA9
We've got ONETest assays for various respiratory viruses (including #coronavirus), genome capture as well as EnviroScreen to detect pathogens in environmental samples. Want to try it in your lab? Get in touch! 2/2 buff.ly/39svBF9
What is ONETest? It's a target-capture platform that offers a sequencer-agnostic, end-to-end #NGS workflow, including library prep, probe-based liquid phase hybridization, and cloud-based bioinformatics analysis. 1/2 #diagnostics #respiratory buff.ly/39svBF9
Want to take “undiagnosed infection” out of medical vocabulary? We're applying novel DNA/RNA capture & informatics tech to overcome the limitations of current infectious-disease diagnostic tests & are looking for scientists to join our #Vancouver team. buff.ly/2U50x8F




















